InsidersTradesSigma
멕아이씨에스 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 멕아이씨에스 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 멕아이씨에스 has recorded 58 reports. Market capitalisation: €26.3bn. The latest transaction was disclosed on 6 May 2026 (Other). Among the most active insiders: 김종철. Every trade is accessible without an account.
56
Insider Decl.
n/a
Thresholds
€19,322
35 ops.
Buy Volume
n/a
4 ops.
Sell Volume
8Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,146 of 27,757 companies
28.0
score / 100
Value16
Quality40
FCF yld-11%
Earn yld-11%
EV/EBITDA·
ROE·
Gross mgn55%
Net mgn-22%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 May 2026
Declarations58 total
Other
Other(filed)
Other
Other(filed)
25 of 58 declarations
About 멕아이씨에스
멕아이씨에스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX. It specializes in developing innovative solutions for the medical field.